Rhythm Pharmaceuticals, Inc. RYTM Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $62.14M+14.4% | $54.3M+4.3% | $52.08M-61.6% | $135.59M+27.8% | $106.1M+19.0% | ||
| $278.49M-16.8% | $334.65M-8.1% | $363.97M+134% | $155.44M-25.4% | $208.39M-10.0% | ||
| $119.43M+15.9% | $103.06M+7.9% | $95.49M+16.8% | $81.77M+11.6% | $73.24M+4.5% | ||
| $95.38M+10.8% | $86.05M+8.9% | $79.04M+11.6% | $70.82M+10.8% | $63.95M+20.3% | ||
| $430.09M-7.9% | $466.92M-5.6% | $494.8M+37.2% | $360.68M-2.3% | $369.29M-1.3% | ||
| $1.07M-3.5% | $1.1M+366% | $237K-20.2% | $297K-35.7% | $462K-26.9% | ||
| $5.11M-4.0% | $5.32M-3.9% | $5.53M-3.7% | $5.75M-3.6% | $5.96M-3.5% | ||
| $442.32M-7.9% | $480.2M-5.3% | $506.87M+36.0% | $372.73M-3.6% | $386.69M-1.4% | ||
| $12.3M-11.8% | $13.95M+2.3% | $13.63M-14.7% | $15.98M+34.2% | $11.91M-3.4% | ||
| —— | —— | —— | —— | $1.3M+1.1% | ||
| $10.13M+38.8% | $7.3M+31.3% | $5.56M— | —— | —— | ||
| $103.2M-2.6% | $105.94M+1.6% | $104.27M-19.5% | $129.46M+15.8% | $111.82M-3.2% | ||
| $98.34M-2.5% | $100.89M-2.4% | $103.41M— | —— | —— | ||
| $204.7M-2.6% | $210.17M-0.5% | $211.19M-11.7% | $239.15M+7.0% | $223.6M-1.8% | ||
| 120M0.0% | 120M+179,004% | 67K+4.7% | 64K+3.2% | 62K+1.6% | ||
| -$1.41B-4.1% | -$1.35B-3.6% | -$1.3B-4.2% | -$1.25B-3.9% | -$1.2B-4.3% | ||
| $122.91M-11.6% | $139.07M-6.6% | $148.82M+1,350% | -$11.91M-163% | $18.95M-12.8% | ||
| $442.32M-7.9% | $480.2M-5.3% | $506.87M+36.0% | $372.73M-3.6% | $386.69M-1.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Rhythm Pharmaceuticals, Inc.'s total assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) holds $442.3M in total assets, up 14.4% year over year.
- How much debt does Rhythm Pharmaceuticals, Inc. have?
- Rhythm Pharmaceuticals, Inc. carries $112.3M in total debt against $122.9M of shareholders' equity, a debt-to-equity ratio of 0.91.
- How much cash does Rhythm Pharmaceuticals, Inc. have?
- Rhythm Pharmaceuticals, Inc. holds $62.1M in cash and equivalents.
- Can Rhythm Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 4.17 — current assets exceed current liabilities.
- Where does Rhythm Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
